iopromide has been researched along with Glioblastoma in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zipp, L | 1 |
| Schwartz, KM | 1 |
| Hewer, E | 1 |
| Yu, Y | 1 |
| Stippich, C | 1 |
| Slopis, JM | 1 |
1 other study available for iopromide and Glioblastoma
| Article | Year |
|---|---|
Magnetic resonance imaging and computed tomography findings in pediatric giant cell glioblastoma.
Topics: Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cerebral Ventricles; Child; Contrast Media; Diffusion Ma | 2012 |